Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04918784 · ClinicalTrials.gov registry record · NA
Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers
A NA study, sponsored by Acera Surgical.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT04918784 is a NA study that has completed, run by Acera Surgical. The registered enrollment target is 46 participants.
The verdict
NCT04918784, a NA study, has completed, sponsored by Acera Surgical.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of the following prospective, randomized, controlled clinical trial is to compare synthetic hybrid-scale fiber matrix (Restrata®, Acera Surgical, Inc.) with standard of care in treating diabetic foot ulcers in human subjects.
Interventions
- DEVICE Restrata®
- DEVICE Wound Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04918784
The ClinicalTrials.gov registry entry for NCT04918784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Acera Surgical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Restrata® is the first listed.
NCT04918784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04918784 about?
NCT04918784 is a clinical study titled "Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers". The purpose of the following prospective, randomized, controlled clinical trial is to compare synthetic hybrid-scale fiber matrix (Restrata®, Acera Surgical, Inc.) with standard of care in treating diabetic foot ulcers in human subjects.
What is the current status of trial NCT04918784?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-05-05. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT04918784?
The interventions under investigation include: Restrata® (DEVICE), Wound Dressing (DEVICE).
Who is sponsoring clinical trial NCT04918784?
This trial is sponsored by Acera Surgical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.